Published in Catheter Cardiovasc Interv on March 01, 2010
Radial Artery Occlusion After Transradial Interventions: A Systematic Review and Meta-Analysis. J Am Heart Assoc (2016) 0.94
Feasibility of transradial coronary intervention using a sheathless guiding catheter in patients with small radial artery. Korean Circ J (2011) 0.81
Using sheathless standard guiding catheters for transradial percutaneous coronary intervention to treat bifurcation lesions. Exp Clin Cardiol (2013) 0.75
Smaller is better. But bigger is smaller. History or the future? What the? Catheter Cardiovasc Interv (2010) 0.75
Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA (2012) 3.71
Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trials. Heart (2011) 2.87
Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. JACC Cardiovasc Interv (2013) 2.08
Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol (2008) 2.01
Both estrogen receptor subtypes, alpha and beta, attenuate cardiovascular remodeling in aldosterone salt-treated rats. Hypertension (2007) 1.68
The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovasc Res (2005) 1.66
Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy. Europace (2009) 1.62
Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice? JACC Cardiovasc Interv (2013) 1.58
The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch Toxicol (2010) 1.58
Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets. Bioinformatics (2011) 1.57
Endothelial nitric oxide synthase activity is inhibited by the plasma membrane calcium ATPase in human endothelial cells. Cardiovasc Res (2010) 1.51
Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis. Eur Heart J (2010) 1.51
What strategies are effective for exercise adherence in heart failure? A systematic review of controlled studies. Heart Fail Rev (2012) 1.49
Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats. Hypertension (2006) 1.49
Calcineurin in human heart hypertrophy. Circulation (2002) 1.47
Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: results from the INFUSE-AMI study. Catheter Cardiovasc Interv (2013) 1.45
The use of a guide catheter extension system as an aid during transradial percutaneous coronary intervention of coronary artery bypass grafts. Catheter Cardiovasc Interv (2011) 1.43
The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction. Eur J Heart Fail (2010) 1.43
Oestrogen action on the myocardium in vivo: specific and permissive for angiotensin-converting enzyme inhibition. J Hypertens (2002) 1.42
The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex. J Biol Chem (2006) 1.41
Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms. EuroIntervention (2012) 1.40
Stent fracture: Insights on mechanisms, treatments, and outcomes from the food and drug administration manufacturer and user facility device experience database. Catheter Cardiovasc Interv (2014) 1.39
A comparison of drug-eluting stents versus bare metal stents in saphenous vein graft PCI outcomes: a meta-analysis. J Interv Cardiol (2011) 1.38
Plasma membrane Ca2+ ATPase 4 is required for sperm motility and male fertility. J Biol Chem (2004) 1.37
Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children. Am J Gastroenterol (2007) 1.35
Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy. Hum Mol Genet (2006) 1.30
Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b. Circulation (2007) 1.27
Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol (2007) 1.26
A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Fail (2009) 1.24
Distal stent delivery with Guideliner catheter: first in man experience. Catheter Cardiovasc Interv (2010) 1.23
Targeted proteolysis sustains calcineurin activation. Circulation (2005) 1.21
Interaction of the plasma membrane Ca2+ pump 4b/CI with the Ca2+/calmodulin-dependent membrane-associated kinase CASK. J Biol Chem (2003) 1.19
Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart. Circulation (2011) 1.18
Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction. Circulation (2005) 1.17
The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit. J Biol Chem (2005) 1.14
Role of advanced glycation end products in cardiovascular disease. World J Cardiol (2012) 1.13
Novel functional interaction between the plasma membrane Ca2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1). J Biol Chem (2004) 1.12
Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth. Circ Res (2009) 1.11
Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circ Res (2007) 1.10
Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury. Am J Physiol Heart Circ Physiol (2011) 1.10
Commentary on "Hybrid iFR-FFR decision-making strategy..." by Petraco et al. EuroIntervention (2013) 1.08
Myocardial infarction after aspirin treatment. J R Soc Med (2005) 1.07
Letter by Williams et al regarding article, "incidence and clinical impact of stent fracture after everolimus-eluting stent implantation". Circ Cardiovasc Interv (2013) 1.07
Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart. Circ Res (2010) 1.06
Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. Cardiovasc Res (2007) 1.06
The health workforce crisis in TB control: a report from high-burden countries. Hum Resour Health (2005) 1.04
Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience. EuroIntervention (2012) 1.02
Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: one-year results from the INFUSE-AMI trial. Circ Cardiovasc Interv (2013) 1.02
Resting Pd/Pa measured with intracoronary pressure wire strongly predicts fractional flow reserve. J Invasive Cardiol (2010) 0.99
Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated? J Card Fail (2010) 0.98
Specific role of neuronal nitric-oxide synthase when tethered to the plasma membrane calcium pump in regulating the beta-adrenergic signal in the myocardium. J Biol Chem (2009) 0.96
Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy. Circ Res (2006) 0.96
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study. EuroIntervention (2012) 0.96
Percutaneous coronary intervention of unprotected left main coronary artery disease as culprit lesion in patients with acute myocardial infarction. JACC Cardiovasc Interv (2011) 0.96
Minimising radial injury: prevention is better than cure. EuroIntervention (2014) 0.96
Regulation of vascular tone in animals overexpressing the sarcolemmal calcium pump. J Biol Chem (2003) 0.95
Improvement of endothelial dysfunction by selective estrogen receptor-alpha stimulation in ovariectomized SHR. Hypertension (2003) 0.94
Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomain. J Biol Chem (2011) 0.93
Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial. EuroIntervention (2007) 0.92
What can we learn from patients with heart failure about exercise adherence? A systematic review of qualitative papers. Health Psychol (2011) 0.92
Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy. Circulation (2009) 0.92
The interaction between endogenous calcineurin and the plasma membrane calcium-dependent ATPase is isoform specific in breast cancer cells. FEBS Lett (2007) 0.92
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin. Circ Heart Fail (2013) 0.91
Biomarker-guided therapies in heart failure: a forum for unified strategies. J Card Fail (2013) 0.91
AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathway. FASEB J (2002) 0.90
Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. J Am Coll Cardiol (2002) 0.89
Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats. Biochem Biophys Res Commun (2005) 0.89
Ca2+ signalling in cardiovascular disease: the role of the plasma membrane calcium pumps. Sci China Life Sci (2011) 0.89
Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook. Bioanalysis (2011) 0.87
Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention. EuroIntervention (2011) 0.87
Gender impact on prognosis of acute coronary syndrome patients treated with drug-eluting stents. Am J Cardiol (2012) 0.87
A novel method for the detection of transient myocardial ischaemia using body surface electrocardiac mapping. Int J Cardiol (2004) 0.86
Physiological implications of the interaction between the plasma membrane calcium pump and nNOS. Pflugers Arch (2008) 0.86
The molecular basis of myocardial hypertrophy and heart failure. Trends Mol Med (2003) 0.86
Serum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury. Front Physiol (2013) 0.86
What influences physical activity in people with heart failure?: a qualitative study. Int J Nurs Stud (2011) 0.86